HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C D Bucana Selected Research

C D Bucana Research Topics

Disease

20Neoplasms (Cancer)
06/2009 - 03/2000
15Neoplasm Metastasis (Metastasis)
06/2009 - 03/2000
10Colonic Neoplasms (Colon Cancer)
11/2002 - 03/2000
8Carcinoma (Carcinomatosis)
11/2002 - 03/2000
4Melanoma (Melanoma, Malignant)
08/2003 - 03/2000
3Ascites
11/2002 - 10/2000
3Peritoneal Neoplasms
11/2002 - 02/2001
2Stomach Neoplasms (Stomach Cancer)
03/2003 - 05/2002
2Colorectal Neoplasms (Colorectal Cancer)
11/2002 - 08/2000
2Prostatic Neoplasms (Prostate Cancer)
07/2001 - 06/2000
2Adenocarcinoma
01/2001 - 12/2000
2Malignant Pleural Effusion
12/2000 - 03/2000
1Breast Neoplasms (Breast Cancer)
06/2009
1Bone Diseases (Bone Disease)
06/2009
1Retinal Degeneration
08/2001
1Retinal Neovascularization
08/2001
1Starvation
03/2001
1Endometrial Neoplasms (Endometrial Cancer)
01/2001
1Papillary Adenocarcinoma
01/2001
1Lung Neoplasms (Lung Cancer)
12/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2000
1Hyperplasia
11/2000
1Ovarian Neoplasms (Ovarian Cancer)
10/2000
1Adenocarcinoma of Lung
03/2000
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2000

Drug/Important Bio-Agent (IBA)

14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003 - 03/2000
7Proteins (Proteins, Gene)FDA Link
03/2003 - 03/2000
6Interleukin-8 (Interleukin 8)IBA
08/2003 - 03/2000
6Messenger RNA (mRNA)IBA
03/2003 - 03/2000
4Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2003 - 11/2000
4ErbB Receptors (EGF Receptor)IBA
03/2003 - 11/2000
4NF-kappa B (NF-kB)IBA
07/2001 - 03/2000
3Epidermal Growth Factor (EGF)IBA
03/2003 - 08/2001
3Angiopoietin-1IBA
11/2002 - 02/2001
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2002 - 03/2000
3NF-KappaB Inhibitor alphaIBA
07/2001 - 03/2000
2Biomarkers (Surrogate Marker)IBA
06/2009 - 10/2001
2ParaffinIBA
06/2009 - 03/2000
2Interferon-betaIBA
08/2003 - 11/2000
2orantinib (SU6668)IBA
10/2001 - 02/2001
2Tyrosine Kinase InhibitorsIBA
10/2001 - 02/2001
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2001 - 03/2000
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2001 - 08/2000
2Cadherins (E-Cadherin)IBA
06/2000 - 03/2000
2Collagenases (Collagenase)FDA Link
06/2000 - 03/2000
2Matrix Metalloproteinases (MMPs)IBA
06/2000 - 03/2000
1Chemokine ReceptorsIBA
06/2009
1Progesterone Receptors (Progesterone Receptor)IBA
06/2009
1Estrogen ReceptorsIBA
06/2009
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
03/2003
1Neuropilin-1IBA
03/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2001
1Angiopoietin-2IBA
09/2001
1Oxygen (Dioxygen)IBA
08/2001
1Cetuximab (Erbitux)FDA Link
08/2001
1AntibodiesIBA
08/2001
1Transcription Factor RelAIBA
07/2001
1TeaIBA
03/2001
1Interferon-alpha (Interferon Alfa)IBA
03/2001
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2001
1Growth Factor ReceptorsIBA
02/2001
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2001
1Complementary DNA (cDNA)IBA
02/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2001
1CytokinesIBA
01/2001
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2000
1Tissue Inhibitor of Metalloproteinase-2IBA
12/2000
1Transforming Growth Factor alpha (TGF-alpha)IBA
11/2000
1Keratins (Keratin)IBA
09/2000
1SilverIBA
09/2000
1Melanins (Melanin)IBA
09/2000
1VimentinIBA
09/2000
1Coloring Agents (Dyes)IBA
09/2000
1Ethanol (Ethyl Alcohol)IBA
09/2000
1aloe emodinIBA
09/2000
1Phosphates (Orthophosphate)IBA
08/2000
1Prostate-Specific Antigen (Semenogelase)IBA
06/2000
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2000
1LipopeptidesIBA
05/2000
1Immunologic Factors (Immunomodulators)IBA
05/2000
1Interleukin-15 (Interleukin 15)IBA
05/2000
1Irinotecan (Camptosar)FDA LinkGeneric
05/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2000
1JBT-3002IBA
05/2000
1ChemokinesIBA
03/2000
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2000
1vatalanib (PTK787)IBA
03/2000
1Formaldehyde (Formol)FDA Link
03/2000
1Imatinib Mesylate (Gleevec)FDA Link
03/2000

Therapy/Procedure

7Therapeutics
06/2009 - 05/2000
3Intraperitoneal Injections
08/2001 - 05/2000
1Injections
03/2001
1Intravenous Injections
12/2000
1Prostatectomy (Retropubic Prostatectomy)
06/2000
1Drug Therapy (Chemotherapy)
05/2000
1Immunomodulation
05/2000